Back to Search
Start Over
A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.
- Source :
- Journal of Thoracic Oncology; 2011 Aug, Vol. 6 Issue 8, p1435-1437, 3p
- Publication Year :
- 2011
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 6
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 108192088
- Full Text :
- https://doi.org/10.1097/JTO.0b013e318223c099